Citation:
Kunadhasan, J., Clark, ED., et al., 2026. Sudden Unexpected Death in the Pfizer BNT162b2 Trial: A Pharmacovigilance Failure. Medical Research Archives, [online] 14(8)
Abstract:
Objective: To characterize the Sudden Unexpected Death (SUD) signal in the Pfizer/BioNTech BNT162b2 mRNA vaccine clinical trial (C4591001) and evaluate factors that may have obscured its detection.
Methods: We conducted a forensic analysis of original trial documents released through litigation and public transparency efforts. All-cause mortality within the first six months was reviewed, with sudden unexpected death defined as death occurring suddenly and unexpectedly in an apparently stable individual.
Results: Of 38 all-cause deaths reported in the six-month interim report, 15 met criteria for sudden unexpected death: 10 in the vaccinated group and 5 in the placebo group. This represents a two-fold increase in sudden unexpected death incidence in the vaccinated group compared to placebo. Autopsy data were unavailable for the majority of cases; only four of the 15 sudden unexpected deaths underwent autopsy, with original reports not provided. The reported cause of death for eight cases was “cardiac arrest” or “cardiopulmonary arrest,” descriptions that do not elucidate underlying etiology. One death was attributed to “sudden cardiac death” and another to “aortic rupture,” suggesting autopsy findings were summarized but not detailed in the case report forms. Age-stratified analysis indicated a shift toward younger age at death among vaccinated males with sudden unexpected death compared to placebo.
Conclusions: The sudden unexpected death signal in the BNT162b2 trial was obscured by three methodological factors: (
1) exclusion of sudden death from the predefined list of adverse events requiring special monitoring,
(2) inconsistent reporting of dates of death, and (
3) absence of standardized autopsy data.
These limitations impeded comprehensive safety-signal detection. Future trials of novel ‘vaccine’ platforms should include sudden death as a predefined outcome requiring special monitoring and mandate autopsy for unexpected deaths to enable accurate causality assessment.
Key words: Sudden Unexpected Death, Sudden Cardiac Death, Autopsy, Pfizer/BioNTech Protocol C4591001.
HEADLINE FINDINGS
The modified messenger RNA/lipid nanoparticle platform that was used to administer the COVID shots, and now is the platform for most new ‘vaccines’, was never proven to be safe in the first place. 2 weeks research injecting mice, followed later in the #PfizerClinicalTrial by destruction of the placebo (CONTROL) group, meant that the chance of documenting medium and long-term safety signals had gone.
As a NOVEL platform for administering drugs to humans, you would at least want to know if the people who ‘DIED SUDDENLY’ having received the shots in the trial had an autopsy to determine the cause of death. but NO!
How can we trust the platform, going forward, even for cancer treatment, without proper ongoing safety trials?
All we hear is the ‘SAFE AND EFFECTIVE’ mantra
Keep asking questions…..
No one died suddenly and unexpectedly from Covid vaccines.
technically i would expect deaths in every nanoparticle trial
badprotein.substack.com/p/modernacarditis
badprotein.substack.com/primum-non-curare